Atrovent and Spinraza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atrovent (ipratropium bromide) and Spinraza (nusinersen sodium). Common drug interactions include pneumonia among females and cardiac arrest among males.

The phase IV clinical study analyzes what interactions people have when they take Atrovent and Spinraza. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Atrovent?

Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 33,210 Atrovent users. Check the latest studies of Atrovent.

What is Spinraza?

Spinraza has active ingredients of nusinersen sodium. eHealthMe is studying from 7,063 Spinraza users. Check the latest studies of Spinraza.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

16 people who take Atrovent and Spinraza together, and have interactions are studied.

Atrovent and Spinraza drug interactions.

What are the common drug interactions of Atrovent and Spinraza, by gender? *:

female:

Pneumonia
Procedural pain
Atrophy (wasting away of a part of the body)
Body temperature decreased
Bradycardia (abnormally slow heart action)
Cardiac arrest
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Enzyme abnormality
Gastrin secretion disorder (gastrin is produced at excessive levels)
Heart rate decreased

male:

Cardiac arrest
Acute respiratory failure
Post lumbar puncture syndrome
Bronchial secretion retention
Fluid retention (an abnormal accumulation of fluid in the blood)
Hypoxic-ischaemic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total)
Inflammation
Malaise (a feeling of general discomfort or uneasiness)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Oxygen saturation decreased

What are the common drug interactions of Atrovent and Spinraza, by age (0-1 to 60+)? *:

0-1:

Atrophy (wasting away of a part of the body)
Body temperature decreased
Bradycardia (abnormally slow heart action)
Cardiac arrest
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Enzyme abnormality
Gastrin secretion disorder (gastrin is produced at excessive levels)
Heart rate decreased
Hyperhidrosis (abnormally increased sweating)
Hypertension (high blood pressure)

2-9:

Cardiac arrest
Oxygen saturation decreased
Decreased immune responsiveness
Diarrhoea
Enzyme abnormality
Gastric haemorrhage (bleeding stomach)
Gastrin secretion disorder (gastrin is produced at excessive levels)
Gastritis (inflammation of stomach)
Heart rate decreased
Heart rate increased

10-19:

Post lumbar puncture syndrome
Spinal muscular atrophy (wasting of spinal muscles)
Acute respiratory failure
Chest discomfort
Contrast media reaction (reaction associated with the use of intravenous contrast material during radiology)
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Ependymoma (tumour in the brain)
Fluid retention (an abnormal accumulation of fluid in the blood)
Gastrointestinal infection (infection of stomach and intestine)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Spinal Muscular Atrophy (wasting of spinal muscles): 15 people, 93.75%
Respiratory Distress (difficulty in breathing): 5 people, 31.25%
The Flu (the flu is caused by an influenza virus): 1 person, 6.25%
Secretion Discharge: 1 person, 6.25%
Flatulence (flatus expelled through the anus): 1 person, 6.25%
Fever: 1 person, 6.25%
Dyspnea (difficult or laboured breathing): 1 person, 6.25%
Cough: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Atrovent and Spinraza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously